The tritium RBE at low-level exposure--variation with dose, dose rate, and exposure duration

Area of Science:

• Radiobiology
• Radiation Oncology
• Nuclear Energy Safety

Background:

• Tritium (3H) is a key component in nuclear energy operations, necessitating accurate assessment of its biological effectiveness.
• Existing data on the relative biological effectiveness (RBE) of tritium beta-radiation compared to standard gamma-rays show significant variability.
• Understanding tritium's RBE is crucial for evaluating risks associated with chronic, low-level radiation exposure, particularly given the limited data from protracted irradiation studies.

Purpose of the Study:

• To experimentally determine the RBE of tritium (3H) beta-radiation relative to gamma-rays under chronic, low-level exposure conditions.
• To investigate the influence of dose, dose rate, and exposure duration on tritium's RBE.
• To clarify discrepancies in reported RBE values for tritium and provide a more robust basis for hazard assessment.

Main Methods:

• Utilized a sensitive mammalian model (mouse oocytes) to measure in vivo cell killing from low-level exposures.
• Administered tritium (as HTO in body water) and continuous 60Co gamma-irradiation at controlled, protracted dose rates.
• Quantified oocyte survival and determined dose-response curves for various gamma-ray dose rates to assess cellular recovery capacity.

Main Results:

• The RBE of tritium was found to be greater than 1 and to increase as the exposure dose decreased, ranging from 1.6 at 50 rad to 2.5 at 25 rad (uncorrected).
• Corrected RBE values approached 2.8, aligning with some previous findings but remaining below theoretical predictions.
• Observed inverse relationship between RBE and dose, and a dose-rate effect, suggesting incomplete cellular recovery even at low dose rates (3.2 rad/day).
• Protracted exposures showed higher RBE (2.0 at 30 rad) compared to shorter exposures (1.4 at 30 rad), potentially due to tritium incorporation into critical cellular sites.

Conclusions:

• The RBE of tritium is dose-dependent and increases with decreasing dose, particularly under protracted exposure conditions.
• Cellular recovery mechanisms in prepubertal mouse oocytes are limited, contributing to the observed RBE variations.
• Systematic variations in RBE with dose, dose rate, and duration explain historical discrepancies and enhance the accuracy of chronic low-level tritium exposure hazard evaluations.